Imaging techniques are enhancing our understanding of the myocardial microcirculation and providing insights into the early stages of microvascular dysfunction in people with diabetes.
Increased risk for nonarteritic anterior ischemic optic neuropathy associated with semaglutide treatment in people with type 2 diabetes is not as great as previously reported.
Berberine ursodeoxycholate, a gut–liver anti-inflammatory metabolic modulator, significantly reduces HbA1c and improves hepatic and cardiometabolic parameters in people with type 2 diabetes.
Recommendations proposed to reduce glycemic variability and improve glycemic management in people with type 1 diabetes, focusing on physical activity, dietary habits, insulin therapy, and other causes of increased variability.
Complete heterozygous deletion of HNF1B was incidentally discovered in a woman who was enrolled in a clinical trial for type 1 diabetes and received immunosuppressive treatment for 4 years when she was a child.
With the growing importance of primary care in diabetes, this podcast discusses the evidence on continuous glucose monitoring (CGM) use, the role of primary healthcare, and practical tips for interpreting the ambulatory glucose profile (AGP) report.
Complete heterozygous deletion of HNF1B was incidentally discovered in a woman who was enrolled in a clinical trial for type 1 diabetes and received immunosuppressive treatment for 4 years when she was a child.
Semaglutide therapy achieved weight loss and reduced cocaine craving in a man with obesity and chronic cocaine abuse. Could this be a new strategy to address substance craving in patients with comorbid obesity?
Adding empagliflozin to sulfonylurea improved glycemic control in a woman with maturity-onset diabetes of the young. No adverse effects were noted, including no increase in ketonemia or ketonuria.
Despite many recent advances in its management, type 1 diabetes remains a burden for those living with the condition.
Prof. Chantal Mathieu explains the progress being made with disease-modifying therapy for type 1 diabetes and how it has the potential to transform the current treatment landscape.
Unhealthy lifestyles have contributed to an increase of type 2 diabetes (T2D) cases worldwide, affecting more than 536.6 million people in 2021 [ 1 ]. Several risk factors are associated with T2D, including physical inactivity, obesity, and weight …
Chronic diabetes mellitus (DM) is common globally. Many epidemiological research on DM prevalence have been done in recent decades [ 25 ]. Vascular complications are the most deadly DM symptoms [ 26 ]. Diabetes-related microvascular complications …
The accumulation of acquired somatic mutations is a natural consequence of ageing, but the pathophysiological implications of these mutations beyond cancer are only beginning to be understood. Most somatic mutations are functionally neutral, but a …
Obesity and type-2 diabetes mellitus (T2DM) are interrelated metabolic disorders primarily driven by overnutrition and physical inactivity, which oftentimes entails a transition from obesity to T2DM. Compromised musculoskeletal health consistently …
Refine the application of CGM technology in primary care to enhance the management of type 2 diabetes. Benefit from key updates and experiential learning using CGM devices, and practice your clinical decision-making skills.
Stay up to date with the rapidly changing CGM landscape. Learn how to implement and integrate CGM into diabetes management to improve patient care and outcomes.
Expert guidance on the multidisciplinary approach to identifying and managing chronic kidney disease in patients with type 2 diabetes, plus patient scenarios to assist your decision-making and put the latest clinical guidelines into context.
This program is not available to users in the UK and US.
Unhealthy lifestyles have contributed to an increase of type 2 diabetes (T2D) cases worldwide, affecting more than 536.6 million people in 2021 [ 1 ]. Several risk factors are associated with T2D, including physical inactivity, obesity, and weight …
Gestational Diabetes Mellitus (GDM) may be defined as carbohydrate intolerance resulting in hyperglycaemia of variable severity with first onset or recognition during pregnancy [ 1 ]. The majority of GDM cases are due to impaired glucose tolerance …
Diabetic retinopathy is a common complication of diabetes that may result in sight loss [ 1 , 2 ]. Early treatment of sight-threatening diabetic retinopathy (STDR) can prevent or delay sight loss, and hence early diagnosis is key [ 3 ]. For this …
Manufactured melatonin is used globally to relieve sleep problems and jet lag, with its usage increasing the past decade even at doses above 5 mg/day [ 1 ]. Melatonin is a hormone constitutively secreted predominantly by the pineal gland, with …
Imaging techniques are enhancing our understanding of the myocardial microcirculation and providing insights into the early stages of microvascular dysfunction in people with diabetes.
Imaging techniques are enhancing our understanding of the myocardial microcirculation and providing insights into the early stages of microvascular dysfunction in people with diabetes.
Imaging techniques are enhancing our understanding of the myocardial microcirculation and providing insights into the early stages of microvascular dysfunction in people with diabetes.
Recommendations proposed to reduce glycemic variability and improve glycemic management in people with type 1 diabetes, focusing on physical activity, dietary habits, insulin therapy, and other causes of increased variability.
